Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-04-05 Lowrance David L Chief Financial Officer Exercise or conversion +320 $1.51 $483 320
2019-04-05 Lowrance David L Chief Financial Officer Sale −320 $9.00 $3K 0
2019-04-05 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −320 92,918
2019-04-05 Jouhikainen Jaakko Taneli President and COO Sale −849 $9.00 $8K 183,905
2019-04-04 Lowrance David L Chief Financial Officer Exercise or conversion +2,446 $1.51 $4K 2,446
2019-04-04 Lowrance David L Chief Financial Officer Sale −2,446 $9.00 $22K 0
2019-04-04 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −2,446 93,238
2019-04-04 Jouhikainen Jaakko Taneli President and COO Sale −7,815 $9.00 $70K 184,754
2019-02-04 Elam Nevan C Director Exercise or conversion +21,682 $0.19 $4K 21,682
2019-02-04 Elam Nevan C Director Exercise or conversion · Stock Option (Right to Buy) −21,682 0
2018-12-21 Neville Robert N Chief Executive Officer Purchase +23,517 $6.38 $150K 498,028
2018-12-13 Elam Nevan C Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-12-13 Pauls Matthew Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-12-13 RAMSAY DAVID A Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-12-13 PIKOVER YURI Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-12-13 McCracken Joseph S Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-12-13 Hawkins Richard J Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2018-11-01 Lowrance David L Chief Financial Officer Sale −18,480 $9.22 $170K 0
2018-08-02 Jouhikainen Jaakko Taneli Grant or award · Stock Option (Right to Buy) +375,000 375,000
2018-08-02 Neville Robert N Chief Executive Officer Grant or award · Stock Option (Right to Buy) +400,000 400,000

Page 17 of 20 · 390 trades